Navigation Links
Vyopta Granted Cisco Preferred Solution Developer Partner Status, Highest Level for Cisco Developer Network
Date:3/11/2013

Austin, Texas (PRWEB) March 11, 2013

To take advantage of the benefits of the expanding role of the network, Vyopta Incorporated, the leading developer of business intelligence and process automation applications for video collaboration, today announced that it is now a Preferred Solution Developer within the TelePresence and Collaboration technology category of Cisco’s Developer Network Program.

Vyopta software applications (vAnalytics™, vAccess™, vPublish™, vSchedule™ and vControl®) fuse business video products into end-to-end solutions that transform the way companies utilize video. Vyopta solutions set the standard in quality, scalability and robust capabilities to support a variety of customer use cases, from automation and management of workflows for video collaboration, lecture capture and publishing, to powerful business analytics that transform the way companies measure the impact of video on their business.

The Cisco Developer Network unites Cisco with third-party developers of hardware and software to deliver tested interoperable solutions to joint customers, harnessing the power and intelligence of the network. As a Preferred Solution Developer, Vyopta has worked closely with Cisco to deliver enhanced solutions that deliver greater interoperability with Cisco networking solutions. Vyopta also shares Cisco’s strong commitment to customer service and satisfaction, has completed interoperability verification testing based on criteria set forth by Cisco, and can provide their customers comprehensive support. With Vyopta products, customers can more quickly deploy a broad range of Cisco Compatible business applications, devices, or services that can enhance the capabilities, performance, and management of the Cisco network. For more information on Vyopta interoperability with Cisco, visit http://www.vyopta.com.

“We are proud to have achieved Preferred Solution Developer Partner Status with Cisco,” said Alfredo Ramirez, President and CEO of Vyopta. “Teaming with Cisco further enables customers to benefit from interoperable solutions that transform how they collaborate, sell, educate, deliver patient care, and more.”

About Vyopta Incorporated
Vyopta is the leading developer of applications for video collaboration, enabling operations intelligence, customer service and content publishing automation that unleash the power of interactive video communications. Vyopta enables companies to do more with video – revolutionizing the way they sell, service, communicate and innovate. For more information on Vyopta, visit http://www.vyopta.com.

  • Interoperability testing is designed to simulate typical customer configurations, and does not replace the need for on-site testing in conjunction with actual implementation.

Vyopta and vControl are registered trademarks of Vyopta Incorporated, and the trademarks of the Vyopta family of products are trademarks of Vyopta Incorporated. All other trademarks referenced herein are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/VyoptaCDN/prweb10497051.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tired Couples May Take Each Other For Granted
2. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
3. Professional Healthcare at Home Offering Geriatric Care Management Services in the San Francisco Bay Area
4. Fast Growing San Francisco Chiropractic Clinic Welcomes New Doctor, Dr. Anthony Gustin
5. Sean Sullivan San Francisco Real Estate New Construction: Discusses ”The Heights” In Pacific Heights, 14 New Luxury Condos
6. Damaka introduces Xabr™, a Native Mobile Video & Collaboration Client for Cisco® Jabber®, CallManager, and TelePresence
7. Paramount Lists Will Be Speaking At The National Postal Forum In San Francisco
8. Using an HRA to Comply with San Francisco's HCSO Requirements - Zane Benefits Publishes Information
9. American Society of Human Genetics to hold 2012 annual meeting, Nov. 6 to 10, in San Francisco
10. San Francisco is Hosting EB-5 Conference July 19, 2012
11. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: